InvestmentPitch Media Video Discusses Reliq Health’s Signing of New Contracts in Nevada with a Primary Care Organization that Includes 6 Clinics, and a Maxillofacial Surgery Practice

Rhea-AI Summary

Reliq Health Technologies Inc. (OTCPink:RQHTF) has announced new contracts in Nevada, partnering with a primary care organization operating six clinics and a Maxillofacial Surgery practice. This expansion is expected to onboard over 3,000 eligible patients to its iUGO Care platform, generating revenue of approximately $50 per patient per month. The company anticipates $450 in revenue per surgery for short-term monitoring and a total monthly revenue of over CDN$190,000 once fully onboarded. Reliq's innovative Virtual Care solutions aim to enhance healthcare delivery.

Positive

• New contracts signed with a primary care organization and a Maxillofacial Surgery practice in Nevada.
• Expected to onboard over 3,000 patients to iUGO Care, generating $50 per patient per month.
• Anticipated revenue of more than $450 per patient per surgery for short-term monitoring.
• Projected monthly revenue exceeding CDN$190,000 once fully operational.

Negative

• None.

VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global telemedicine company developing innovative Virtual Care solutions for the multibillion-dollar Healthcare market, has signed new contracts in Nevada with a primary care organization that includes 6 clinics, and with a Maxillofacial Surgery practice. Maxillofacial surgeons specialise in the diagnosis and treatment of diseases affecting the mouth, jaws, face and neck.

Dr. Lisa Crossley, CEO, stated: “We continue to rapidly expand our customer base in Nevada. The primary care organization brings six clinics and over 3,000 eligible patients to our iUGO Care platform at an average revenue of $50 per patient per month. We are very excited to also be expanding into the Maxillofacial Surgery space through our new contract with an oral surgery practice in Nevada. Oral surgeons can generate new revenue by using iUGO Care to provide pre- and post-op monitoring and care management for their diabetic patients. Once the patient has successfully recovered from surgery their care can be transferred back to the primary care physician for ongoing monitoring through iUGO Care, providing the primary care physician with immediate access to an already established recurring revenue stream.”

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Reliq” in the search box.

Reliq expects to generate more than $450 per patient per surgery for short-term monitoring, followed by recurring revenue of $50 per patient per month as care is transferred back to the patient’s primary care physician. Each oral surgery practice typically works closely with multiple physician practices, providing Reliq with a new channel through which it can access new primary care clients. When the 3,000 patients are fully onboarded and generating revenues of US$50 per patient per month, the company anticipates generating revenue of more than CDN$190,000 per month.

Based in Hamilton, Ontario, with offices in Florida and Texas, Reliq specializes in developing innovative Virtual Care solutions for the multi-billion dollar healthcare market. The company’s powerful iUGO Care technology platform is a comprehensive SaaS solution that allows complex patients to receive high-quality care at home, improving health outcomes, enhancing the quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and emergency room visits.

The shares are trading at $0.78. For more information, please visit the company’s website, www.ReliqHealth.com or email IR@ReliqHealth.com. Investor Relations in the United States is handled by Ben Shamsian of Lytham Partners, who can be reached at 649-829-9701 or by email at shamsian@LythamPartners.com.

Disclaimer

The information in this Investmentpitch Media Ltd video is for the viewers information only. Reliq Health Technologies has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format. The corporate information is based on information that is publicly available. Any information provided by Investmentpitch Media Ltd., through its media services is not to be construed as a recommendation or suggestion or offer to buy or sell securities but is provided solely as an informational media service. Investmentpitch Media Ltd makes no warranties or undertakings as to the accuracy or completeness of this information. All due diligence should be done by the viewer or their financial advisor. Investing in securities is speculative and carries risk.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com